Gaucher Disease Type 1 Latest Advances
Find the Latest Research About Gaucher Disease Type 1
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 400 publications
Paediatric Gaucher disease type 1: diagnostic challenges in presence of hepatosplenomegaly and pancytopenia
Journal: Annales de biologie clinique
Published: July 21, 2026
Efficacy and safety of eliglustat tartrate in adults with Gaucher disease type 1
Journal: Zhonghua yi xue za zhi
Published: May 20, 2026
Age-Specific Parkinson Disease Risk in Gaucher Disease Type 1: Data From the ICGG Gaucher Registry.
Journal: Neurology
Published: May 05, 2026
Clinical Experience With Eliglustat in Children With Gaucher Disease Type 1.
Journal: American journal of medical genetics. Part A
Published: April 27, 2026
persistent pain and fatigue drive reduced quality of life in treated Gaucher disease type 1: a cross-sectional analysis.
Journal: Orphanet journal of rare diseases
Published: April 09, 2026
Left Ventricular Global Longitudinal Strain as an Early Predictor of Disease Severity Progression in Gaucher Disease Type 1.
Journal: Echocardiography (Mount Kisco, N.Y.)
Published: March 12, 2026
A 53-week, open-label phase IIIb study of velaglucerase alfa in Chinese patients with type 1 Gaucher disease: Safety, efficacy, and pharmacokinetics.
Journal: Molecular genetics and metabolism reports
Published: March 02, 2026
Increased intervals in enzyme replacement therapy for stable type 1 Gaucher disease: A non-inferiority sequential trial emulation.
Journal: Journal of internal medicine
Published: February 28, 2026
Transcriptomic Profiling of Monozygotic Twins with Type 1 Gaucher Disease.
Journal: Life (Basel, Switzerland)
Published: February 18, 2026
The cutaneous phenotypic landscape of Gaucher disease type 1: a clinic-based cross-sectional study.
Journal: Journal of the American Academy of Dermatology
Published: February 12, 2026
The cutaneous phenotypic landscape of Gaucher disease type 1: A clinic-based cross-sectional study.
Journal: Journal of the American Academy of Dermatology
Published: February 12, 2026
Improvement of Bone Mineral Density in Patients with Type 1 Gaucher Disease Treated with Velaglucerase Alfa: Results from Clinical Studies.
Journal: Journal of clinical medicine
Published: January 19, 2026
Last Updated: 09/26/2026